1-8 of 8
Niketa C. Shah
Close
Sort by
Journal Articles

Abatacept-Prophylaxis Based Haploidentical Transplantation May Allow Sustained Engraftment and Offset Gvhd in Non-Malignant Disorders

Alexander I. Ngwube, Niketa C. Shah, Ginny Schulz, Lakshmanan Krishnamurti, Shalini Shenoy
Journal: Blood
Blood (2023) 142 (Supplement 1): 4901.
https://doi.org/10.1182/blood-2023-191145
Published: 2023
Journal Articles

Outcomes after RIC and Abatacept-Based Acute and Chronic Gvhd Prophylaxis in Allogeneic Transplantation for Sickle Cell Disease - Can Calcineurin Inhibitor Use be Curtailed?

Niketa C. Shah, Alexander I. Ngwube, David A Jacobsohn, Shalini Shenoy
Journal: Blood
Blood (2023) 142 (Supplement 1): 2185.
https://doi.org/10.1182/blood-2023-190524
Published: 2023
Journal Articles

Congenital Dyserythropoietic Anemia Type II: An Update from the Congenital Dyseryhtropoietic Anemia Registry of North America (CDAR)

Yasmin Elgammal, Mary Risinger, Ammar Husami, Joseph Walden, Sweta Gupta, Niketa C. Shah, James Boyer, Yasmina L. Abajas, Michael Winstead, David W. Miller, Viviana Vidal-Anaya, Adrianna Vlachos, Ashutosh Lal, Arthur K. Ritchey, Robert Lorsbach, Wenying Zhang, Theodosia A. Kalfa, Omar Niss
Journal: Blood
Blood (2023) 142 (Supplement 1): 1079.
https://doi.org/10.1182/blood-2023-189389
Published: 2023
Journal Articles

Endothelial Complications of Hematopoietic Cell Transplantation for Sickle Cell Disease

Aron Flagg, Rohaum Hamidi, Yanhong Deng, Niketa C. Shah, Lakshmanan Krishnamurti, Zili He
Journal: Blood
Blood (2022) 140 (Supplement 1): 10460–10461.
https://doi.org/10.1182/blood-2022-169107
Published: 2022
Journal Articles

Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL

Jessica Stiefel, Allyson M. Flower, Marissa Botwinick, Maegan Ford, Alycia Foti, Mital Gandhi, Justin Slovin, Elana Smilow, Ashley Bowers, Hannah Karpel, Leya Y Schwartz, Ellen Fraint, Lisa M. Gennarini, Sharon L. Gardner, Elizabeth A. Raetz, Niketa C. Shah, Jing Chen, Jennifer Krajewski, Nobuko Hijiya, Prakash Satwani, Jessica C Hochberg, Audrey Mauguen, Kevin J. Curran, Maria Luisa Sulis
Journal: Blood
Blood (2022) 140 (Supplement 1): 7763–7765.
https://doi.org/10.1182/blood-2022-160272
Published: 2022
Journal Articles

Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease

Niketa C. Shah, MD, Sweta Bhoopatiraju, Allistair Abraham, MD, Eric Jon Anderson, MD, Martin Andreansky, MD, Monica Bhatia, MD, Sonali Chaudhury, MD, Geoff D.E. Cuvelier, MD, Kamar Godder, MD MPH, Michael Grimley, MD, Gregory Hale, MD, Naynesh Kamani, David Jacobsohn, MD, Alexander I. Ngwube, MD, Jodi L. Skiles, MD, Lolie C. Yu, MD, Shalini Shenoy, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
https://doi.org/10.1182/blood-2020-142696
Published: 2020
Journal Articles

Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)

Alexander I. Ngwube, MD, Niketa C. Shah, MD, David Jacobsohn, MD, Edward Dela Ziga, MD, Shalini Shenoy, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 370.
https://doi.org/10.1182/blood-2019-126405
Published: 2019
Journal Articles

Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL

Vanessa Fabrizio, MD, Farid Boulad, MD, Maria I. Cancio, MD, Meghan A. Higman, MD PhD, Steven P. Margossian, MD PhD, Audrey Mauguen, PhD, Susan Prockop, MD, Andromachi Scaradavou, MD, Niketa C. Shah, MD, Barbara Spitzer, MD, Nick Yeager, Nancy A. Kernan, Richard O'Reilly, MD, Jaap Jan Boelens, MD PhD, Kevin J. Curran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4582.
https://doi.org/10.1182/blood-2019-121767
Published: 2019